Recent Quotes (30 days)

You have no recent quotes
chg | %

Pyng Medical Corp.  

(Public, CVE:PYT)   Watch this stock  
Find more results for PYT
0.0000 (0.00%)
Mar 2 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.03 - 0.03
52 week 0.02 - 0.07
Open 0.03
Vol / Avg. 15,000.00/6,097.00
Mkt cap 707,620.00
P/E     -
Div/yield     -
EPS -0.03
Shares 23.59M
Beta 0.24
Inst. own     -
Jan 14, 2015
Q4 2014 Pyng Medical Corp Earnings Release

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin -25.56% -15.09%
Operating margin -15.73% -8.54%
EBITD margin - 3.77%
Return on average assets -21.57% -11.93%
Return on average equity -36.43% -21.76%
CDP Score - -


210 - 13480 Crestwood Place
+1-604-3037964 (Phone)
+1-604-3037987 (Fax)

Website links


Pyng Medical Corp., (Pyng) is a Canada-based medical device company. The Company discovers, develops, manufactures and markets a suite of trauma and resuscitation products. Pyng is in the business of producing and selling the FAST1 Intraosseous Infusion System, TPOD Pelvic Stabilizer, MAT Tourniquet, and developing FASTx Sternal Intraosseous Device. Pyng offers medical devices for use by hospital staff, emergency medical services and military forces worldwide. The T-POD Pelvic Stabilizer device provides immediate treatment of simple and complex pelvic fractures by binding the pelvis to reduce pain, bleeding, or haemorrhage, morbidity, and mortality risks. CRIC is indicated for use in obtaining a surgical airway for patients where intubation is not an option and the product provides a rapid Cricothyroidotomy solution (including illumination) in a single compact device. The Company operates in Canada and the United States.

Officers and directors

Ronald Blanck Independent Chairman of the Board
Mark F. Hodge President, Chief Executive Officer
George G. Dorin Chief Financial Officer, Corporate Secretary
Age: 60
Robert Di Silvio Director
Age: 61
Alan L. Moloff Director
Herbert A. Toms III Director
L. J. Evans Jr. Independent Director